参考文献/References:
[1]叶峥嵘,杨晓航,吴琳.温阳法治疗肿瘤的临床应用与基础研究进展[J].陕西中医学院学报,2011,34(1):88-91.
[2]叶峥嵘,杨晓航,吴琳.阳和汤治疗肿瘤的临床应用与实验研究进展[J].陕西中医学院学报,2011,34(4):90-93.
[3]叶峥嵘,杨晓航,吴琳,等.基于温阳法治疗肿瘤探讨阳和汤药组配伍对H22荷瘤小鼠抑瘤作用及IL-2?IL-4影响[J].辽宁中医药大学学报,2017,19(7):106-109.
[4]陈新莲,林胜友.中医学对瘕积聚认识及意义[J].江西中医药,2009,40(11):5-6.
[5]叶峥嵘,杨晓航,吴琳,等.基于性激素—肿瘤免疫微环境研究两种温阳法抑瘤作用机制区别与联系的理论探讨[J].中国中医基础医学杂志,2012,18(8):903-905.
[6]邓芳柏,赵小青,刘良.温阳解凝之阳和汤治疗肺癌浅析[J].中医药通报,2006,5(3):23-26.
[7]李尧,钱文慧,陆茵,等.中医治则治法与肿瘤微环境[J].中医杂志,2011,52(21):1801-1804.
[8]赵远红.恶性肿瘤“温药和之”解析[J].新中医,2008,40(7):100.
[9]林丽珠,肖志伟.中西医结合治疗肿瘤的几点思考[J].中医杂志,2012,53(18):1554-1556?
[10] Lan RY, Selmi C, Gershwin ME. The regulatory, inflame matory, and T cell programming roles of interleukin -2 ( IL-2) [ J] . Autoimmun. 2008,31( 1) :7 -12.
[ 11] Gruenbacher G, Gander H, Nussbaumer O, etal. IL - 2costimulation enables statin - mediated activation of humanNK cells, preferentially through a mechanism involvingCD56 + dendritic cells[ J] . Cancer Res, 2010, 70( 23) :9611 -9620.
[12] Yang H, Cheng EY, Sharma VK, etal. Dendritic cells withTGF - β1 and IL -2 differentiate naive CD4 + T cells intoalloantigen - specific and allograft protective Foxp3 + regulatory T cells [ J] . Transplantation, 2012, 93 ( 6) : 580-588.
[13] Bullock TN, Mullins DW, Colella TA, etal. Manipulationof avidity to improve effectiveness of adoptively transferredCD8 + T cells for melanoma immunotherapy in humanMHC classl - transgenic mice [ J] . Immunol, 2001, 167( 10) :5824 -5831.
[14] Basse P, Goldfarb RH. Localization of immune effectorcells to tumor metastases[ J] . Immunology, 1994, 61: 149-158.
[15] Waldmaan Y. The IL -2 / IL -2 receptor system: a targetfor rationl immune interrention [ J] . Immunology Today,1993,14( 6) :264 -270.
[16] Sasaki K, Pardee AD, Qu Y, etal. IL - 4 suppresses VeryLate Antigen -4 expression which is required for therapeutic Th1 T cell trafficking into tumors[ J] . Immunother,2009,32( 8) :793 -802.